Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Hiddensecretson Jan 14, 2021 9:36pm
213 Views
Post# 32303508

RE:Medivolve can capitalize on 50 billion new funds for testing

RE:Medivolve can capitalize on 50 billion new funds for testingThanks Sarb999,

I was just going to post this. 

INCREDIBLE AVALANCHE of money coming our way, pot has $ 50 billion for testing and $ 20 billion for vaccination and Biden wants mobile units.    We are mobile units.

Lets get 5% of this amount of $ 2.5 billion. 

We are all set up.

The $ 5 million PP will come just in time.   This Somherville CEO has eyes of a shark, he timed it perfectly with the Biden plan which will become law in the week we get the funds. 

A visionary CEO is such an incredible asset to have, he ran a $ 1.5 billion operation at Teva.   He is always 5 steps ahead of everyone.

The appointment of the doctor today is another signal that he is planning an aggressive move in another direction in parallel with covid19 in the health and wellness market, which is TELEMEDECINE, another HUGE MARKET. 

MPO
<< Previous
Bullboard Posts
Next >>